Approval · Notice of Compliance 18972 · 2017
REVOLUTION: Notice of Compliance 18972
Issued February 13, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18972
- Date
- February 13, 2017
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVOLUTION | 02242045 | Marketed |
| REVOLUTION | 02242046 | Marketed |
| REVOLUTION | 02242047 | Marketed |
| REVOLUTION | 02242048 | Marketed |
| REVOLUTION | 02242049 | Marketed |
| REVOLUTION | 02242050 | Marketed |
| REVOLUTION | 02279339 | Marketed |
| REVOLUTION | 02367343 | Marketed |
Medicinal ingredients
- SELAMECTIN 240 MG per 2ML
- SELAMECTIN 120 MG per 2ML
- SELAMECTIN 30 MG per 0.25ML
- SELAMECTIN 45 MG per 0.75ML
- SELAMECTIN 60 MG per 0.5ML
- SELAMECTIN 15 MG per 0.25ML
- SELAMECTIN 360 MG per 3ML
- SELAMECTIN 60 MG per ML